Aeterna Zentaris Inc - ESG Rating & Company Profile powered by AI
The Disclosure rating includes 17 UN SDGs including: 'Good Health & Wellbeing', 'Industry, Innovation & Infrastructure' and 'Peace, Justice & Strong Institutions'. This SDG rating for Aeterna Zentaris Inc indicates the company's reporting of the United Nations Sustainable Development Goals. Other corporations in the scoring industry group for Aeterna Zentaris Inc are displayed.
Aeterna Zentaris Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.8; made up of an environmental score of 2.7, social score of 4.8 and governance score of 4.0.
3.8
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1089 | Zymeworks Inc | 3.9 | Medium |
1089 | bluebird bio Inc | 3.9 | Medium |
1112 | Aeterna Zentaris Inc | 3.8 | Medium |
1112 | AcelRx Pharmaceuticals Inc | 3.8 | Medium |
1112 | Arcus Biosciences Inc | 3.8 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Aeterna Zentaris Inc have an accelerator or VC vehicle to help deliver innovation?
Does Aeterna Zentaris Inc disclose current and historical energy intensity?
Does Aeterna Zentaris Inc report the average age of the workforce?
Does Aeterna Zentaris Inc reference operational or capital allocation in relation to climate change?
Does Aeterna Zentaris Inc disclose its ethnicity pay gap?
Does Aeterna Zentaris Inc disclose cybersecurity risks?
Does Aeterna Zentaris Inc offer flexible work?
Does Aeterna Zentaris Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Aeterna Zentaris Inc disclose the number of employees in R&D functions?
Does Aeterna Zentaris Inc conduct supply chain audits?
Does Aeterna Zentaris Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Aeterna Zentaris Inc conduct 360 degree staff reviews?
Does Aeterna Zentaris Inc disclose the individual responsible for D&I?
Does Aeterna Zentaris Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Aeterna Zentaris Inc disclose current and / or historical scope 2 emissions?
Does Aeterna Zentaris Inc disclose water use targets?
Does Aeterna Zentaris Inc have careers partnerships with academic institutions?
Did Aeterna Zentaris Inc have a product recall in the last two years?
Does Aeterna Zentaris Inc disclose incidents of discrimination?
Does Aeterna Zentaris Inc allow for Work Councils/Collective Agreements to be formed?
Has Aeterna Zentaris Inc issued a profit warning in the past 24 months?
Does Aeterna Zentaris Inc disclose parental leave metrics?
Does Aeterna Zentaris Inc disclose climate scenario or pathway analysis?
Does Aeterna Zentaris Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Aeterna Zentaris Inc disclose the pay ratio of women to men?
Does Aeterna Zentaris Inc support suppliers with sustainability related research and development?
Does Aeterna Zentaris Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Aeterna Zentaris Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Aeterna Zentaris Inc involved in embryonic stem cell research?
Does Aeterna Zentaris Inc disclose GHG and Air Emissions intensity?
Does Aeterna Zentaris Inc disclose its waste policy?
Does Aeterna Zentaris Inc report according to TCFD requirements?
Does Aeterna Zentaris Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Aeterna Zentaris Inc disclose energy use targets?
Does Aeterna Zentaris Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Aeterna Zentaris Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Aeterna Zentaris Inc
These potential risks are based on the size, segment and geographies of the company.
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. The company markets macimorelin under the Macrilen brand name. Aeterna Zentaris Inc. has a license agreement with University Wuerzburg to research, develop, manufacture, and sell a potential COVID-19 vaccine; development, manufacture, and commercialization of the treatment for neuromyelitis optica spectrum disorder; and to develop human 3D intestinal tissue models to study infection biology; and for pre-clinical development towards the potential treatment of Parkinson's disease. It also has a license agreement with Consilient Health Ltd., Novo Nordisk Novo Nordisk Health Care AG, and NK MEDITECH Ltd. for the development and commercialization of macimorelin in the United States and Canada, as well as The University of Sheffield, the United Kingdom for the research, development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of primary hypoparathyroidism. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.